185 related articles for article (PubMed ID: 21245094)
1. Smad4 inactivation promotes malignancy and drug resistance of colon cancer.
Papageorgis P; Cheng K; Ozturk S; Gong Y; Lambert AW; Abdolmaleky HM; Zhou JR; Thiagalingam S
Cancer Res; 2011 Feb; 71(3):998-1008. PubMed ID: 21245094
[TBL] [Abstract][Full Text] [Related]
2. 15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1α expression in human colon cancer cells.
Wu Y; Mao F; Zuo X; Moussalli MJ; Elias E; Xu W; Shureiqi I
Cancer Med; 2014 Jun; 3(3):472-84. PubMed ID: 24634093
[TBL] [Abstract][Full Text] [Related]
3. Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.
Wong CK; Lambert AW; Ozturk S; Papageorgis P; Lopez D; Shen N; Sen Z; Abdolmaleky HM; Győrffy B; Feng H; Thiagalingam S
Mol Cancer Res; 2020 Mar; 18(3):414-423. PubMed ID: 31932471
[TBL] [Abstract][Full Text] [Related]
4. Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer.
Johnson SAS; Lin JJ; Walkey CJ; Leathers MP; Coarfa C; Johnson DL
Oncotarget; 2017 Jul; 8(30):48832-48845. PubMed ID: 28415573
[TBL] [Abstract][Full Text] [Related]
5. BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential.
Miah S; Banks CAS; Ogunbolude Y; Bagu ET; Berg JM; Saraf A; Tettey TT; Hattem G; Dayebgadoh G; Kempf CG; Sardiu M; Napper S; Florens L; Lukong KE; Washburn MP
Sci Adv; 2019 Oct; 5(10):eaaw3113. PubMed ID: 31681835
[TBL] [Abstract][Full Text] [Related]
6. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells.
Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS
Front Immunol; 2020; 11():570683. PubMed ID: 33424832
[TBL] [Abstract][Full Text] [Related]
7. A protective role by interleukin-17F in colon tumorigenesis.
Tong Z; Yang XO; Yan H; Liu W; Niu X; Shi Y; Fang W; Xiong B; Wan Y; Dong C
PLoS One; 2012; 7(4):e34959. PubMed ID: 22509371
[TBL] [Abstract][Full Text] [Related]
8. SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium.
Perekatt AO; Shah PP; Cheung S; Jariwala N; Wu A; Gandhi V; Kumar N; Feng Q; Patel N; Chen L; Joshi S; Zhou A; Taketo MM; Xing J; White E; Gao N; Gatza ML; Verzi MP
Cancer Res; 2018 Sep; 78(17):4878-4890. PubMed ID: 29986996
[TBL] [Abstract][Full Text] [Related]
9. TIAF1 self-aggregation in peritumor capsule formation, spontaneous activation of SMAD-responsive promoter in p53-deficient environment, and cell death.
Chang JY; Chiang MF; Lin SR; Lee MH; He H; Chou PY; Chen SJ; Chen YA; Yang LY; Lai FJ; Hsieh CC; Hsieh TH; Sheu HM; Sze CI; Chang NS
Cell Death Dis; 2012 Apr; 3(4):e302. PubMed ID: 22534828
[TBL] [Abstract][Full Text] [Related]
10. De-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGFβ-deficient squamous cell carcinoma from transition zones.
McCauley HA; Chevrier V; Birnbaum D; Guasch G
Elife; 2017 Feb; 6():. PubMed ID: 28219480
[TBL] [Abstract][Full Text] [Related]
11. TGFΒ-induced transcription in cancer.
Cantelli G; Crosas-Molist E; Georgouli M; Sanz-Moreno V
Semin Cancer Biol; 2017 Feb; 42():60-69. PubMed ID: 27586372
[TBL] [Abstract][Full Text] [Related]
12. Metastatic site influences driver gene function in pancreatic cancer.
Tsanov KM; Barriga FM; Ho YJ; Alonso-Curbelo D; Livshits G; Koche RP; Baslan T; Simon J; Tian S; Wuest AN; Luan W; Wilkinson JE; Masilionis I; Dimitrova N; Iacobuzio-Donahue CA; Chaligné R; Pe'er D; Massagué J; Lowe SW
bioRxiv; 2024 Mar; ():. PubMed ID: 38562717
[TBL] [Abstract][Full Text] [Related]
13. Metapopulation dynamics and spatial heterogeneity in cancer.
González-García I; Solé RV; Costa J
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13085-9. PubMed ID: 12351679
[TBL] [Abstract][Full Text] [Related]
14. Partners in crime: the TGFβ and MAPK pathways in cancer progression.
Chapnick DA; Warner L; Bernet J; Rao T; Liu X
Cell Biosci; 2011 Dec; 1():42. PubMed ID: 22204556
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.
Venken T; Miller IS; Arijs I; Thomas V; Barat A; Betge J; Zhan T; Gaiser T; Ebert MP; O'Farrell AC; Prehn J; Klinger R; O'Connor DP; Moulton B; Murphy V; Serna G; Nuciforo PG; McDermott R; Bird B; Leonard G; Grogan L; Horgan A; Schulte N; Moehler M; Lambrechts D; Byrne AT
NPJ Genom Med; 2024 May; 9(1):33. PubMed ID: 38811554
[TBL] [Abstract][Full Text] [Related]
16. The Antagonistic and Synergistic Role of Fe
Szlasa W; Mazurek W; Szewczyk A; Rembiałkowska N; Tunikowska J; Kulbacka J
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794222
[TBL] [Abstract][Full Text] [Related]
17. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma.
Wang Y; Liu S; Wang Y; Li B; Liang J; Chen Y; Tang B; Yu S; Wang H
Cell Death Discov; 2024 May; 10(1):252. PubMed ID: 38789418
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus-miRNA-BART6-5p regulates TGF-β/SMAD4 pathway to induce glycolysis and enhance proliferation and metastasis of gastric cancer cells.
Zhao X; Huang X; Dang C; Wang X; Qi Y; Li H
Oncol Res; 2024; 32(5):999-1009. PubMed ID: 38686046
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer.
Kurowska N; Madej M; Strzalka-Mrozik B
Curr Issues Mol Biol; 2023 Dec; 46(1):121-139. PubMed ID: 38248312
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenesis in colorectal cancer therapy.
Yang Z; Zhang X; Bai X; Xi X; Liu W; Zhong W
Cancer Sci; 2024 Mar; 115(3):734-751. PubMed ID: 38233340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
